Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: EGLN3[original query] |
---|
Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility. Endocrine-related cancer 2011 Feb 18 (1): 73-83. Astuti Dewi, Ricketts Christopher J, Chowdhury Rasheduzzaman, McDonough Michael A, Gentle Dean, Kirby Gail, Schlisio Susanne, Kenchappa Rajappa S, Carter Bruce D, Kaelin William G, Ratcliffe Peter J, Schofield Christopher J, Latif Farida, Maher Eamonn |
Genetic markers of bevacizumab-induced hypertension. Angiogenesis 2014 Jul 17 (3): 685-94. Lambrechts Diether, Moisse Matthieu, Delmar Paul, Miles David W, Leighl Natasha, Escudier Bernard, Van Cutsem Eric, Bansal Aruna T, Carmeliet Peter, Scherer Stefan J, de Haas Sanne, Pallaud Celi |
Whole-Genome Sequencing Identifies the Egl Nine Homologue 3 (egln3/phd3) and Protein Phosphatase 1 Regulatory Inhibitor Subunit 2 (PPP1R2P1) Associated with High-Altitude Polycythemia in Tibetans at High Altitude. Disease markers 2019 12 2019 5946461. Gesang Luobu, Gusang Lamu, Dawa Ciren, Gesang Gawa, Li Ka |
Unique mutations in mitochondrial DNA and associated pathways involved in high altitude pulmonary edema susceptibility in Indian lowlanders. Journal of biomolecular structure & dynamics 2022 6 1-16. Sharma Swati, Sandhir Rajat, Ganju Lilly, Kumar Bhuvnesh, Singh Yami |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: